No black box warning on record for Fluopar

As of the latest FDA labeling reviewed, Fluopar (FLUOCINONIDE, DIMETHICONE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Fluopar medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS •Fluocinonide Cream USP, 0.1% has been shown to suppress the HPA axis. Systemic absorption of Fluocinonide Cream USP, 0.1% may produce reversible hypothalamic-pituitary-adrenal (HPA) axis suppression, Cushing’s syndrome, hyperglycemia and unmask latent diabetes (5.1) •Systemic absorption may require evaluation for HPA axis suppression (5.1) •Modify use should HPA axis su

No black box warning on record for Fluopar

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS •Fluocinonide Cream USP, 0.1% has been shown to suppress the HPA axis. Systemic absorption of Fluocinonide Cream USP, 0.1% may produce reversible hypothalamic-pituitary-adrenal (HPA) axis suppression, Cushing’s syndrome, hyperglycemia and unmask latent diabetes (5.1) •Systemic absorption may require evaluation for HPA axis suppression (5.1) •Modify use should HPA axis su

Fluopar Black Box Warning

No black box warning on record for Fluopar

Other warnings & precautions

Fluopar Black Box Warning

No black box warning on record for Fluopar

Other warnings & precautions